文献速递临床免疫分子诊断

COVID-19快速抗原自测的阳性出现时间可预测SARS-CoV-2病毒载量:一项概念验证研究

Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept.
PubMed 文献 · Clin Chem Lab Med · 2022-11-01

该概念验证研究验证SARS-CoV-2自测快速诊断试验(RDT)的阳性出现时间可反映标本实际病毒载量。将高病毒载量阳性样本稀释后同步用分子检测(Xpert Xpress SARS-CoV-2)和RDT(COVID-VIRO ALL IN RDT)检测,用2次多项式曲线拟合Ct值与阳性出现时间,并将参数用于常规患者样本的Ct值估算。结果显示RDT估算与实测Ct值高度相关(r=0.996),在30例连续RDT阳性患者中相关性r=0.522(p=0.003),估算与实测Ct值相关性稍提高至0.577,偏倚可忽略。结论提示RDT有潜力提供急性SARS-CoV-2感染患者的病毒载量信息。

要点

  • RDT阳性出现时间与实测Ct值呈正相关,可用于估算病毒载量。
  • 在30例RDT阳性患者中,阳性出现时间与Ct值相关性r=0.522(p=0.003)。
  • RDT估算Ct值与实测Ct值在<20 cut-off的一致率为80%。

核心结论

  • RDT阳性出现时间可预测SARS-CoV-2病毒载量,具有可行性。

研究设计与样本

  • 概念验证研究:高病毒载量阳性样本稀释后同步用分子检测(Xpert Xpress SARS-CoV-2)和RDT(COVID-VIRO ALL IN RDT)检测。
  • 用2次多项式曲线拟合Ct值与RDT阳性出现时间,参数用于30例连续RDT阳性患者样本的Ct值估算。

主要发现

  • RDT估算与实测Ct值高度相关(r=0.996),Deming拟合 y=1.01×x-0.18。
  • 30例连续RDT阳性患者中,RDT阳性出现时间与实测Ct值相关性 r=0.522(p=0.003)。
  • RDT估算与实测Ct值相关性稍提高至0.577(Deming拟合 y=0.44×x+11.08),偏倚可忽略(1.0;95% CI,-0.2 to 2.2;p=0.105)。
  • RDT估算与实测Ct值在<20 cut-off的一致率为80%,灵敏度0.84,特异度0.73。

关键数值与推荐

  • RDT估算与实测Ct值在<20 cut-off的一致率为80%,灵敏度0.84,特异度0.73。

临床怎么用

  • RDT阳性出现时间可作为病毒载量的半定量指标,辅助评估急性SARS-CoV-2感染患者的传染性。

局限性

  • 本研究为概念验证研究,样本量有限(30例连续患者),需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This proof of concept study was aimed to validate the hypothesis that the time of positivization of SARS-CoV-2 self-performed rapid diagnostic tests (RDTs) may reflect the actual viral load in the specimen. METHODS: A SARS-CoV-2 positive sample with high viral load was diluted and concomitantly assayed with molecular assay (Xpert Xpress SARS-CoV-2) and RDT (COVID-VIRO ALL IN RDT). The (mean cycle threshold; Ct) values and RDT positivization times of these dilutions were plotted and interpolated by calculating the best fit. The parameters of this equation were then used for converting the positivization times into RDT-estimated SARS-CoV-2 Ct values in routine patient samples. RESULTS: The best fit between measured and RDT-estimated Ct values could be achieved with a 2-degree polynomial curve. The RDT-estimated Ct values exhibited high correlation (r=0.996) and excellent Deming fit (y=1.01 × x - 0.18) with measured Ct values. In 30 consecutive patients with positive RDT test, the correlation between RDT positivization time and measured Ct value was r=0.522 (p=0.003). The correlation of RDT-estimated and measured Ct values slightly improved to 0.577 (Deming fit: y=0.44 × x + 11.08), displaying a negligible bias (1.0; 95% CI, -0.2 to 2.2; p=0.105). Concordance of RDT-estimated and measured Ct values at the <20 cut-off was 80%, with 0.84 sensitivity and 0.73 specificity. CONCLUSIONS: This proof of concept study demonstrates the potential feasibility of using RDTs for garnering information on viral load in patients with acute SARS-CoV-2 infection.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Salvagno GL, Henry BM, Bongiovanni G, et al. Positivization time of a COVID-19 rapid antigen self-test predicts SARS-CoV-2 viral load: a proof of concept. Clin Chem Lab Med. 2022. PMID: 36315978. doi:10.1515/cclm-2022-0873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。